Brain microRNAs are associated with variation in cognitive trajectory in advanced age
- PMID: 35105862
- PMCID: PMC8807720
- DOI: 10.1038/s41398-022-01806-3
Brain microRNAs are associated with variation in cognitive trajectory in advanced age
Abstract
In advancing age, some individuals maintain a stable cognitive performance over time, while others experience a rapid decline. Such variation in cognitive trajectory is only partially explained by common neurodegenerative pathologies. Hence, we aimed to identify new molecular processes underlying variation in cognitive trajectory using brain microRNA profile followed by an integrative analysis with brain transcriptome and proteome. Individual cognitive trajectories were derived from longitudinally assessed cognitive-test scores of older-adult brain donors from four longitudinal cohorts. Postmortem brain microRNA profiles, transcriptomes, and proteomes were derived from the dorsolateral prefrontal cortex. The global microRNA association study of cognitive trajectory was performed in a discovery (n = 454) and replication cohort (n = 134), followed by a meta-analysis that identified 6 microRNAs. Among these, miR-132-3p and miR-29a-3p were most significantly associated with cognitive trajectory. They explain 18.2% and 2.0% of the variance of cognitive trajectory, respectively, and act independently of the eight measured neurodegenerative pathologies. Furthermore, integrative transcriptomic and proteomic analyses revealed that miR-132-3p was significantly associated with 24 of the 47 modules of co-expressed genes of the transcriptome, miR-29a-3p with 3 modules, and identified 84 and 214 downstream targets of miR-132-3p and miR-29a-3p, respectively, in cognitive trajectory. This is the first global microRNA study of cognitive trajectory to our knowledge. We identified miR-29a-3p and miR-132-3p as novel and robust contributors to cognitive trajectory independently of the eight known cerebral pathologies. Our findings lay a foundation for future studies investigating mechanisms and developing interventions to enhance cognitive stability in advanced age.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Fig. 1](https://webcf.waybackmachine.org/web/20240721100651im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8807720/bin/41398_2022_1806_Fig1_HTML.gif)
![Fig. 2](https://webcf.waybackmachine.org/web/20240721100651im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8807720/bin/41398_2022_1806_Fig2_HTML.gif)
![Fig. 3](https://webcf.waybackmachine.org/web/20240721100651im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8807720/bin/41398_2022_1806_Fig3_HTML.gif)
![Fig. 4](https://webcf.waybackmachine.org/web/20240721100651im_/https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8807720/bin/41398_2022_1806_Fig4_HTML.gif)
Similar articles
-
Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z. Nat Commun. 2019. PMID: 30962425 Free PMC article.
-
Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia.NPJ Genom Med. 2020 Feb 6;5:6. doi: 10.1038/s41525-019-0113-8. eCollection 2020. NPJ Genom Med. 2020. PMID: 32047652 Free PMC article.
-
MicroRNA-29 differentially mediates preeclampsia-dysregulated cellular responses to cytokines in female and male fetal endothelial cells.J Physiol. 2023 Aug;601(16):3631-3645. doi: 10.1113/JP284746. Epub 2023 Jul 4. J Physiol. 2023. PMID: 37401732 Free PMC article.
-
MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling.Diabetologia. 2023 Feb;66(2):288-299. doi: 10.1007/s00125-022-05809-z. Epub 2022 Oct 21. Diabetologia. 2023. PMID: 36269347 Free PMC article.
-
MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer.Clin Transl Oncol. 2023 Mar;25(3):563-577. doi: 10.1007/s12094-022-02978-6. Epub 2022 Nov 10. Clin Transl Oncol. 2023. PMID: 36355327 Free PMC article. Review.
Cited by
-
The broken Alzheimer's disease genome.Cell Genom. 2024 May 8;4(5):100555. doi: 10.1016/j.xgen.2024.100555. Epub 2024 May 1. Cell Genom. 2024. PMID: 38697121 Free PMC article. Review.
-
Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response.Acta Neuropathol Commun. 2024 Apr 25;12(1):68. doi: 10.1186/s40478-024-01760-9. Acta Neuropathol Commun. 2024. PMID: 38664739 Free PMC article.
-
Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer's pathology.Nat Commun. 2024 Apr 1;15(1):2823. doi: 10.1038/s41467-024-47028-7. Nat Commun. 2024. PMID: 38561349 Free PMC article.
-
Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5×FAD Mice.Mol Neurobiol. 2024 Jun;61(6):3343-3356. doi: 10.1007/s12035-023-03791-0. Epub 2023 Nov 22. Mol Neurobiol. 2024. PMID: 37989983 Free PMC article.
-
Analytical Validation of a Novel MicroRNA Panel for Risk Stratification of Cognitive Impairment.Diagnostics (Basel). 2023 Jun 26;13(13):2170. doi: 10.3390/diagnostics13132170. Diagnostics (Basel). 2023. PMID: 37443567 Free PMC article.
References
-
- Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991;30:572–80. - PubMed
-
- Fabian MR, Sonenberg N. The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol. 2012;19:586–93. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AG072975/AG/NIA NIH HHS/United States
- IK4 BX005219/BX/BLRD VA/United States
- R01 AG061800/AG/NIA NIH HHS/United States
- R01 AG053960/AG/NIA NIH HHS/United States
- R01 AG017917/AG/NIA NIH HHS/United States
- R56 AG062633/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- RC2 AG036547/AG/NIA NIH HHS/United States
- U01 AG046161/AG/NIA NIH HHS/United States
- IK2 BX001820/BX/BLRD VA/United States
- RF1 AG036042/AG/NIA NIH HHS/United States
- U01 AG046152/AG/NIA NIH HHS/United States
- U01 MH115484/MH/NIMH NIH HHS/United States
- RF1 AG015819/AG/NIA NIH HHS/United States
- R01 AG056533/AG/NIA NIH HHS/United States
- I01 BX003853/BX/BLRD VA/United States
- R01 AG036042/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P30 NS055077/NS/NINDS NIH HHS/United States
- R01 AG015819/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources